Health knowledge and news provided by doctors.

Ads by Google

Prostate Cancer Treatment and Symptoms

Earlier Use of Prostate Cancer Vaccines Urged By Hopkins Scientists

Timing is everything when it comes to killing prostate cancer cells with specially tailored vaccines. Most prostate cancer vaccines currently are tested on men whose cancers are growing and no longer responsive to hormone therapy.

Men More Likely to Get Screened for Prostate Cancer Than Colon Cancer,

Prostate screens could be 'teachable moment' to encourage colon checks. What men do pay attention to is prostate cancer. And that has researchers thinking an annual prostate cancer screening might be a good opportunity to urge men to be screened for colon cancer too.

Some Men with Low PSAs Have Prostate Cancer: Most Cancers Found Are Not Likely to Be Clinically Significant

Men with low PSA (prostate specific antigen) levels on screening tests can still have prostate cancer. In this study, prostate cancers were detected by biopsy in men with normal PSA levels.

Combination of Cancer Drugs Increases Survival Rate of Some Prostate Cancer Patients: New Research Shows

Prostate cancer patients whose cancer has spread to other parts of the body and who no longer respond to hormone therapy may benefit from a combination of the cancer drugs docetaxel and estramustine, according to a new study published in the Oct. 8 issue of the New England Journal of Medicine.

Should I be concerned if close relatives are diagnosed with Prostate Cancer?

Having a close relative with prostate cancer is considered a risk factor for developing it yourself. In fact, hereditary prostate cancer accounts for 10 to 15 per cent of all cases and tends to develop at a relatively early age (before the age of 55). An individual who has two first-degree relatives (father and brother) with prostate cancer may be up to eight times more at risk of developing prostate cancer in his lifetime than a man with no family history.

Preventing prostate cancer - what you can do

Prostate cancer is the number one cancer threat to the lives and health of men. It is the most common cancer, and the second most deadly after lung cancer. An increasing number of men are expected to develop the disease in their lifetime, with 19,000 being diagnosed every year.

NIH Launches New Study to Compare Prostate Surgery and Drugs

TUNA and TUMT use heat to destroy part of the enlarged prostate to improve urine flow and symptoms. Early studies suggest that these procedures reduce the occurrence of erection or bladder control side effects, which occur more often with the traditional surgery for BPH, known as transurethral resection of the prostate (TURP).

Combined Drug Therapy Prevents Progression of Prostate Enlargement Helps Men at High Risk Avoid Surgery

A combination of drugs is significantly more effective than either drug alone for preventing progression of benign prostatic hyperplasia (BPH), especially in men at high risk for disease progression.